Life Spine

Life Spine

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $60M

Overview

Life Spine is a privately held medical device company specializing in minimally invasive spinal implants, with a core focus on its expandable interbody spacer systems. The company has a commercial portfolio targeting various spinal regions and recently secured key FDA clearances and MR Conditional status for its flagship ProLift systems. Led by a new CEO, Richard Mueller, Life Spine is positioned in the growing spinal fusion market, competing by offering technologies designed to improve lordosis restoration and reduce complications compared to static implants.

Orthopedic SpineDegenerative Spinal Disorders

Technology Platform

Micro Invasive Expandable Solutions platform centered on expandable interbody spacer technology designed to restore lordosis, disc height, and foraminal height with reduced subsidence compared to static implants.

Funding History

3
Total raised:$60M
Series C$30M
Series B$20M
Series A$10M

Opportunities

The growing, aging population and demand for minimally invasive surgical solutions present a significant market opportunity.
The expandable interbody segment is a high-growth niche where Life Spine's technology directly addresses clinical drawbacks of traditional static implants.

Risk Factors

The company faces intense competition from large, established medical device giants with greater resources.
Success is also highly dependent on surgeon adoption, favorable reimbursement policies, and continuous demonstration of clinical superiority through outcomes data.

Competitive Landscape

Life Spine competes in the crowded spinal implant market against major players like Medtronic, Stryker, NuVasive, and Globus Medical. Its differentiation is primarily through its focus on minimally invasive expandable interbody systems, competing with other specialists in this sub-segment such as SeaSpine, Alphatec, and ZimVie.